148 related articles for article (PubMed ID: 20154024)
1. Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.
Revell AD; Wang D; Harrigan R; Hamers RL; Wensing AM; Dewolf F; Nelson M; Geretti AM; Larder BA
J Antimicrob Chemother; 2010 Apr; 65(4):605-7. PubMed ID: 20154024
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Developments in CD4 and viral load monitoring in resource-limited settings.
Rowley CF
Clin Infect Dis; 2014 Feb; 58(3):407-12. PubMed ID: 24218101
[TBL] [Abstract][Full Text] [Related]
4. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
[TBL] [Abstract][Full Text] [Related]
5. Monitoring HIV viral load in resource limited settings: still a matter of debate?
Arnedo M; Alonso E; Eisenberg N; Ibáñez L; Ferreyra C; Jaén A; Flevaud L; Khamadi S; Roddy P; Gatell JM; Dalmau D;
PLoS One; 2012; 7(12):e47391. PubMed ID: 23236346
[TBL] [Abstract][Full Text] [Related]
6. Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.
Zolfo M; Schapiro JM; Phan V; Koole O; Thai S; Vekemans M; Fransen K; Lynen L
AIDS Res Hum Retroviruses; 2011 Jul; 27(7):727-35. PubMed ID: 20854169
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
[TBL] [Abstract][Full Text] [Related]
8. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.
Phillips AN; Pillay D; Miners AH; Bennett DE; Gilks CF; Lundgren JD
Lancet; 2008 Apr; 371(9622):1443-51. PubMed ID: 18440426
[TBL] [Abstract][Full Text] [Related]
9. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
10. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
Hoffmann CJ; Maritz J; van Zyl GU
Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
[TBL] [Abstract][Full Text] [Related]
11. Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
Bratt G; Karlsson A; Leandersson AC; Albert J; Wahren B; Sandström E
AIDS; 1998 Nov; 12(16):2193-202. PubMed ID: 9833861
[TBL] [Abstract][Full Text] [Related]
12. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
Kumarasamy N; Krishnan S
Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
[TBL] [Abstract][Full Text] [Related]
13. Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings.
Johannessen A; Trøseid M; Calmy A
J Antimicrob Chemother; 2009 Dec; 64(6):1126-9. PubMed ID: 19776036
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of HAART-treated patients in a resource-limited setting: the Belgrade Cohort Study.
Jevtović D; Dragovic G; Salemović D; Ranin J; Kušić J; Marinković J; Djurković-Djaković O
Biomed Pharmacother; 2014 Apr; 68(3):391-5. PubMed ID: 24486106
[TBL] [Abstract][Full Text] [Related]
15. Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy.
Chaiwarith R; Praparattanapan J; Nuntachit N; Kotarathitithum W; Sirisanthana T; Supparatpinyo K
Curr HIV Res; 2011 Mar; 9(2):82-7. PubMed ID: 21361862
[TBL] [Abstract][Full Text] [Related]
16. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia.
Ferradini L; Laureillard D; Prak N; Ngeth C; Fernandez M; Pinoges L; Puertas G; Taburet AM; Ly N; Rouzioux C; Balkan S; Quillet C; Delfraissy JF
AIDS; 2007 Nov; 21(17):2293-301. PubMed ID: 18090277
[TBL] [Abstract][Full Text] [Related]
17. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
Bélec L; Bonn JP
Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
[TBL] [Abstract][Full Text] [Related]
18. Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
Tuboi SH; Pacheco AG; Harrison LH; Stone RA; May M; Brinkhof MW; Dabis F; Egger M; Nash D; Bangsberg D; Braitstein P; Yiannoutsos CT; Wood R; Sprinz E; Schechter M;
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):70-7. PubMed ID: 20035163
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
20. [Optimizing resources to reduce costs to determine HIV viral load in limited resources settings].
Girón-Callejas A; Mendizabal-Burastero R; Yax E; Martínez A; Mejía-Villatoro C
Biomedica; 2017 Dec; 37(4):460-465. PubMed ID: 29373766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
